Factors associated with adherence to BRCA1/2 mutation testing after oncogenetic counseling in long-surviving patients with a previous diagnosis of breast or ovarian cancer. Silvia Actis et al. J Community Genet 2023 9 (Posted Sep 21, 2023 2PM) Rare Diseases

https://phgkb.cdc.gov/PHGKB/specificPHGKB.action?topic=rare&query=home